Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
>
Gene Therapy Protects Kidneys in Preclinical Model of Type 1 Diabetes
Gene Therapy Protects Kidneys in Preclinical Model of Type 1 Diabetes
Read also
Pfizer touts Tukysa in front-line breast cancer after Phase III victory
Pfizer’s Tukysa (tucatinib) has enhanced patient outcomes when used as a maintenance therapy during a late-stage trial in breast cancer.
Telomir Pharmaceuticals reports new preclinical data on pancreatic cancer
Telomir Pharmaceuticals, Inc., a $54 million market cap biotech company whose stock has declined 11% in the past week
Компания 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
FDA grants Fast Track status to Enterome’s EO2463 for follicular lymphoma
Enterome has received fast track designation from the US Food and Drug Administration for its lead OncoMimics immunotherapy EO2463, targeting follicular lymphoma in the low tumour burden ‘watch-and-...
